HIKAL

Pharmaceuticals

Hikal Ltd.

NSE: HIKALBSE: 524735ISIN: INE475B01022

₹217.40

+5.45 · +2.57%

As of 24 Jul 2026

Open

₹211.00

High

₹220.00

Low

₹208.00

Prev Close

₹211.95

52W High

₹336.50

52W Low

₹146.25

Volume

3.44 L

Mkt Cap

₹2,687 Cr

Fundamentals

Valuation & profitability

Market Cap

₹2,687 Cr

P/E Ratio

EPS (TTM)

₹3.51

Book Value

₹96.30

Dividend Yield

0.34%

ROCE

7.81%

ROE

Sales Growth

Face Value

₹2.00

Key highlights

Auto-generated from live data

Trades at a P/E of 62, with a return on equity (ROE) of 6%.
HIKAL is trading above 3 of 5 of its key moving averages (10/20/50/100/200-DMA) — a bullish technical setup.
Year-to-date it is down 6.02%, and down 7.12% over the past year.
At ₹217.40 it sits about 37% of the way up its 52-week range (₹146.25–₹336.50).
Offers a dividend yield of 0.34%.
Market capitalisation stands at ₹2,687 Cr.

Price chart

Daily candles + volume · SMA 20 / 50 / 200 · stored OHLC

Shareholding pattern

Shareholding data syncs daily.

Performance

Stock returns vs Nifty 50

10D

-10.23%

Nifty -0.64%

20D

-3.02%

Nifty -1.72%

50D

+13.52%

Nifty +2.68%

100D

+14.81%

Nifty -1.14%

200D

-5.21%

Nifty -8.93%

YTD

-6.02%

Nifty -8.59%

52W

-7.12%

Nifty -7.86%

Moving averages

Simple moving averages vs current price

3/5 above · Bullish

SMA 10-Day

₹228.19Below

SMA 20-Day

₹226.36Below

SMA 50-Day

₹209.88Above

SMA 100-Day

₹196.13Above

SMA 200-Day

₹210.74Above

Price ranges

Where the price sits in each window

10-Day range₹217.40

₹208.00₹252.80

20-Day range₹217.40

₹208.00₹252.80

50-Day range₹217.40

₹174.97₹252.80

200-Day range₹217.40

₹146.25₹261.00

YTD range₹217.40

₹146.25₹252.80

52-Week range₹217.40

₹146.25₹353.80

Technical signals

Unfilled gaps acting as support / resistance

Unfilled Gap Up On 15 Jun, 2026 : 186.00 ~ 185.20SUPPORT

Unfilled Gap Down On 26 May, 2025 : 398.00 ~ 402.35RESISTANCE

Unfilled Gap Down On 17 Jan, 2022 : 488.00 ~ 491.00RESISTANCE

Unfilled Gap Up On 15 May, 2020 : 109.30 ~ 109.10SUPPORT

Unfilled Gap Up On 09 Apr, 2020 : 94.00 ~ 89.55SUPPORT

Unfilled Gap Up On 08 Apr, 2020 : 85.00 ~ 81.45SUPPORT

Unfilled Gap Up On 07 Apr, 2020 : 77.50 ~ 75.20SUPPORT

Annual financials

Revenue, profit & EPS by financial year

Year	Revenue	Net Profit	EPS	NPM
Mar 2023	₹2,023 Cr	₹78 Cr	₹6.36	3.86%
Mar 2022	₹1,943 Cr	₹161 Cr	₹13.02	8.29%
Mar 2021	₹1,720 Cr	₹133 Cr	₹10.80	7.73%
Mar 2021	₹1,720 Cr	₹133 Cr	₹10.80	7.73%
Mar 2020	₹1,507 Cr	₹84 Cr	₹6.85	5.57%
Mar 2020	₹1,507 Cr	₹84 Cr	₹6.85	5.57%
Mar 2019	₹1,590 Cr	₹103 Cr	₹8.36	6.48%
Mar 2019	₹1,590 Cr	₹103 Cr	₹8.36	6.48%
Mar 2018	₹1,296 Cr	₹77 Cr	₹6.27	5.94%
Mar 2017	₹1,014 Cr	₹68 Cr	₹5.49	6.71%
Mar 2016	₹926 Cr	₹41 Cr	₹3.21	4.43%
Mar 2015	₹872 Cr	₹40 Cr	₹3.14	4.59%

Peer comparison

Other companies in Pharmaceuticals

Company	P/E	Book Value	Sales Growth
SUNPHARMA SUN PHARMACEUTICAL INDUSTRIES LTD.	39.1	₹98.33	10.1%
MARKSANS MARKSANS PHARMA LTD.	23.8	₹11.85	5.8%
MOREPENLAB MOREPEN LABORATORIES LTD.	20.81	₹6.43	16.6%
NEULANDLAB NEULAND LABORATORIES LTD.	23.48	₹542.16	9.35%
GUFICBIO Gufic BioSciences Ltd.	24.16	₹10.85	20.41%
DIVISLAB DIVI'S LABORATORIES LTD.	41.01	₹266.77	9.47%
DRREDDY DR.REDDY'S LABORATORIES LTD.	19.73	₹852.69	1.07%
RPGLIFE RPG LIFE SCIENCES LTD.	17.14	₹105.02	5.73%
GLAND Gland Pharma Ltd	53.6	₹242.00	—
ZYDUSLIFE Zydus Lifesciences Ltd	8.23	₹166.00	5%
SMSPHARMA SMS PHARMACEUTICALS LTD.	9.58	₹42.07	-8.73%
CIPLA CIPLA LTD.	15.36	₹209.71	0.7%

Dividend history

Per share, by ex-date

Ex-Date: 14 Feb 2023₹0.60

Ex-Date: 14 Sept 2022₹0.40

Ex-Date: 23 Feb 2022₹1.20

Ex-Date: 25 Aug 2021₹1.00

Ex-Date: 15 Feb 2021₹1.00

Ex-Date: 07 Sept 2020₹0.20

Ex-Date: 17 Feb 2020₹1.00

Ex-Date: 23 Jul 2019₹0.60

Ex-Date: 13 Feb 2019₹0.60

Ex-Date: 31 Jul 2018₹0.50

Ex-Date: 21 Feb 2018₹0.70

Ex-Date: 02 Aug 2017₹0.60

Bulk & block deals

Recent large transactions

Date	Client	Type	Qty	Price
05 Jun 2013	HIKAL EMPLOYEES WELFARE RUST A TRUST A	SALE	1,50,000	₹393.00
27 Oct 2006	OPPENHEIMER FUNDS	SALE	83,038	₹395.47
26 Sept 2006	EMERGING MARKET MGMT INC	SALE	5,41,404	₹320.00
26 Sept 2006	RELIANCE CAPITAL TRUSTEE	PURCHASE	4,82,000	₹320.00

Explore more

Pharmaceuticals sector

Sector peers & index performance

HIKAL news & filings

Latest corporate announcements

Top Gainers

Biggest NSE gainers today

Top Losers

Biggest NSE losers today

IPO Calendar

Open & upcoming IPOs

Stock Screener

Find more stocks like this

Fundamentals, financials & technicals sourced from niftytrader.in, cached and refreshed periodically.